KIT-Mutated Melanomas Respond to Imatinib

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2013-140
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Imatinib in Pulmonary Arterial Hypertension: C-Kit Inhibition

Pulmonary Circulation
PulmonaryRespiratory Medicine
2014English

KIT Inhibition by Imatinib in Patients With Severe Refractory Asthma

New England Journal of Medicine
Medicine
2017English

CD72 Regulates the Growth of KIT-mutated Leukemia Cell Line Kasumi-1

Scientific Reports
Multidisciplinary
2013English

Successful Treatment of KIT D816v-Positive, Imatinib-Resistant Systemic Mastocytosis With Interferon-Alpha

Internal Medicine
Internal MedicineMedicine
2009English

Rare KIT (CD117) Expression in Multiple Myeloma Abrogates the Usefulness of Imatinib Mesylate Treatment

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2004English

Double Resistance to Imatinib and AMG 706 Caused by Multiple Acquired KIT Exon 17 Mutations in a Gastrointestinal Stromal Tumour

Gut
Gastroenterology
2007English

Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Algorithm to Detect in Situ Melanomas

British Journal of Dermatology
DermatologyMedicine
2018English

The Power to Respond

Nature Energy
Energy EngineeringRenewable EnergyFuel TechnologySustainabilityOpticalMagnetic MaterialsPower TechnologyElectronicthe Environment
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy